KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbCellera Biologics (ABCL) Total Liabilities (2020 - 2026)

AbCellera Biologics filings provide 7 years of Total Liabilities readings, the most recent being $369.0 million for Q1 2026.

  • Quarterly Total Liabilities rose 14.88% to $369.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $369.0 million through Mar 2026, up 14.88% year-over-year, with the annual reading at $390.0 million for FY2025, 28.11% up from the prior year.
  • Total Liabilities hit $369.0 million in Q1 2026 for AbCellera Biologics, down from $390.0 million in the prior quarter.
  • Across five years, Total Liabilities topped out at $395.0 million in Q2 2025 and bottomed at $289.4 million in Q1 2023.
  • Average Total Liabilities over 5 years is $340.8 million, with a median of $333.2 million recorded in 2024.
  • The largest annual shift saw Total Liabilities surged 124.49% in 2022 before it decreased 24.78% in 2023.
  • AbCellera Biologics' Total Liabilities stood at $307.6 million in 2022, then rose by 9.15% to $335.8 million in 2023, then fell by 9.32% to $304.5 million in 2024, then increased by 28.11% to $390.0 million in 2025, then decreased by 5.39% to $369.0 million in 2026.
  • Per Business Quant, the three most recent readings for ABCL's Total Liabilities are $369.0 million (Q1 2026), $390.0 million (Q4 2025), and $392.0 million (Q3 2025).